Home › Brain Tumors › Alabama › Birmingham
Brain Tumors clinical trials in Birmingham, AL
5 studies for Brain Tumors are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecruitingPhase 2
- University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RecruitingPhase 2
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
RecruitingPhase 2
- University of Alabama, Birmingham
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RecruitingPhase 1
- University of Alabama at Birmingham Cancer Center, Birmingham
Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases
Recruiting
- University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center, Birmingham
About Brain Tumors
A brain tumor is a growth of abnormal cells in the brain tissue. Learn the types of tumors, symptoms, how they are diagnosed and treatment options.
More about Brain Tumors on MedlinePlus
Brain Tumors trials in other cities
- Houston, TX35 studies
- Boston, MA28 studies
- New York City, NY25 studies
- Washington, DC20 studies
- Los Angeles, CA16 studies
- Miami, FL15 studies
- Durham, NC14 studies
- St. Louis, MO12 studies
- Rochester, MN12 studies
- Columbus, OH11 studies
- Baltimore, MD11 studies
- Chicago, IL11 studies
Other studies in Birmingham
- Cancer (all types)31 studies
- Breast Cancer24 studies
- Obesity23 studies
- Ovarian Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- Cardiovascular Disease17 studies
- COPD17 studies
- Overweight16 studies
- Cystic Fibrosis16 studies
- Endometrial Cancer16 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.